Europe and UK are investigating a rare nerve-degenerating disorder in some people after likely taking the AstraZeneca-Oxford Covid-19 vaccine.
Reports suggest seven cases of Guillain-Barre syndrome were reported from a medical centre in Kerala as well, where about 1.2 million people were administered the AstraZeneca Covid-19 vaccine, known as Covishield in India.
#Covishield #AstraZeneca #CovidVaccineSideEffect
